BiPar Sciences
Pharmacological company developing parp inhibitors as cancer therapies. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$500m (Public information from Apr 2009)
Brisbane United States (HQ)
Authorizing premium user...